ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Anti-CD20 Monoclonal Antibodies Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-17C10084
Home | Market Reports | Health| Health Conditions| Cancer
Global Anti CD20 Monoclonal Antibodies Market Insights and Forecast to 2028
BUY CHAPTERS

Global Anti-CD20 Monoclonal Antibodies Market Research Report 2025

Code: QYRE-Auto-17C10084
Report
July 2025
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Genmab
Amgen Inc
Celltrion
Roche
Novartis
Pfizer Inc
Biogen
Genentech Inc
Immunomedics
Spectrum Pharmaceuticals
Bio Rad Laboratories
LFB Biotechnologie

Anti-CD20 Monoclonal Antibodies Market

The global market for Anti-CD20 Monoclonal Antibodies was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Anti-CD20 monoclonal antibody is an anti-tumor agent for the treatment of non-hodge B cell malignancy.Unlike conventional treatments, these antibodies attack the CD20 antigen on cancer cells.
North American market for Anti-CD20 Monoclonal Antibodies is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Anti-CD20 Monoclonal Antibodies is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Anti-CD20 Monoclonal Antibodies include Genmab, Amgen, Celltrion, Roche, Novartis AG, Pfizer, Biogen, Genentech, Immunomedics, Spectrum Pharmaceuticals, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Anti-CD20 Monoclonal Antibodies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-CD20 Monoclonal Antibodies.
The Anti-CD20 Monoclonal Antibodies market size, estimations, and forecasts are provided in terms of sales volume (KG) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Anti-CD20 Monoclonal Antibodies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-CD20 Monoclonal Antibodies manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Anti-CD20 Monoclonal Antibodies Market Report

Report Metric Details
Report Name Anti-CD20 Monoclonal Antibodies Market
Segment by Type
  • First Generation Anti-CD20 Monoclonal Antibody
  • Second Generation Anti-CD20 Monoclonal Antibody
  • Third Generation Anti-CD20 Monoclonal Antibody
Segment by Application
  • Oncology
  • Neurology
  • Immunology
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Genmab, Amgen, Celltrion, Roche, Novartis AG, Pfizer, Biogen, Genentech, Immunomedics, Spectrum Pharmaceuticals, Bio-Rad Laboratories, LFB Biotechnologie
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Anti-CD20 Monoclonal Antibodies manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Anti-CD20 Monoclonal Antibodies in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Anti-CD20 Monoclonal Antibodies Market report?

Ans: The main players in the Anti-CD20 Monoclonal Antibodies Market are Genmab, Amgen, Celltrion, Roche, Novartis AG, Pfizer, Biogen, Genentech, Immunomedics, Spectrum Pharmaceuticals, Bio-Rad Laboratories, LFB Biotechnologie

What are the Application segmentation covered in the Anti-CD20 Monoclonal Antibodies Market report?

Ans: The Applications covered in the Anti-CD20 Monoclonal Antibodies Market report are Oncology, Neurology, Immunology

What are the Type segmentation covered in the Anti-CD20 Monoclonal Antibodies Market report?

Ans: The Types covered in the Anti-CD20 Monoclonal Antibodies Market report are First Generation Anti-CD20 Monoclonal Antibody, Second Generation Anti-CD20 Monoclonal Antibody, Third Generation Anti-CD20 Monoclonal Antibody

1 Anti-CD20 Monoclonal Antibodies Market Overview
1.1 Product Definition
1.2 Anti-CD20 Monoclonal Antibodies by Type
1.2.1 Global Anti-CD20 Monoclonal Antibodies Market Value Comparison by Type (2024 VS 2031)
1.2.2 First Generation Anti-CD20 Monoclonal Antibody
1.2.3 Second Generation Anti-CD20 Monoclonal Antibody
1.2.4 Third Generation Anti-CD20 Monoclonal Antibody
1.3 Anti-CD20 Monoclonal Antibodies by Application
1.3.1 Global Anti-CD20 Monoclonal Antibodies Market Value by Application (2024 VS 2031)
1.3.2 Oncology
1.3.3 Neurology
1.3.4 Immunology
1.4 Global Anti-CD20 Monoclonal Antibodies Market Size Estimates and Forecasts
1.4.1 Global Anti-CD20 Monoclonal Antibodies Revenue 2020-2031
1.4.2 Global Anti-CD20 Monoclonal Antibodies Sales 2020-2031
1.4.3 Global Anti-CD20 Monoclonal Antibodies Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Anti-CD20 Monoclonal Antibodies Market Competition by Manufacturers
2.1 Global Anti-CD20 Monoclonal Antibodies Sales Market Share by Manufacturers (2020-2025)
2.2 Global Anti-CD20 Monoclonal Antibodies Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Anti-CD20 Monoclonal Antibodies Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Anti-CD20 Monoclonal Antibodies, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Anti-CD20 Monoclonal Antibodies, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Anti-CD20 Monoclonal Antibodies, Product Type & Application
2.7 Global Key Manufacturers of Anti-CD20 Monoclonal Antibodies, Date of Enter into This Industry
2.8 Global Anti-CD20 Monoclonal Antibodies Market Competitive Situation and Trends
2.8.1 Global Anti-CD20 Monoclonal Antibodies Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Anti-CD20 Monoclonal Antibodies Players Market Share by Revenue
2.8.3 Global Anti-CD20 Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Anti-CD20 Monoclonal Antibodies Market Scenario by Region
3.1 Global Anti-CD20 Monoclonal Antibodies Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Anti-CD20 Monoclonal Antibodies Sales by Region: 2020-2031
3.2.1 Global Anti-CD20 Monoclonal Antibodies Sales by Region: 2020-2025
3.2.2 Global Anti-CD20 Monoclonal Antibodies Sales by Region: 2026-2031
3.3 Global Anti-CD20 Monoclonal Antibodies Revenue by Region: 2020-2031
3.3.1 Global Anti-CD20 Monoclonal Antibodies Revenue by Region: 2020-2025
3.3.2 Global Anti-CD20 Monoclonal Antibodies Revenue by Region: 2026-2031
3.4 North America Anti-CD20 Monoclonal Antibodies Market Facts & Figures by Country
3.4.1 North America Anti-CD20 Monoclonal Antibodies Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Anti-CD20 Monoclonal Antibodies Sales by Country (2020-2031)
3.4.3 North America Anti-CD20 Monoclonal Antibodies Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Anti-CD20 Monoclonal Antibodies Market Facts & Figures by Country
3.5.1 Europe Anti-CD20 Monoclonal Antibodies Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Anti-CD20 Monoclonal Antibodies Sales by Country (2020-2031)
3.5.3 Europe Anti-CD20 Monoclonal Antibodies Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Anti-CD20 Monoclonal Antibodies Market Facts & Figures by Region
3.6.1 Asia Pacific Anti-CD20 Monoclonal Antibodies Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Anti-CD20 Monoclonal Antibodies Sales by Region (2020-2031)
3.6.3 Asia Pacific Anti-CD20 Monoclonal Antibodies Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Anti-CD20 Monoclonal Antibodies Market Facts & Figures by Country
3.7.1 Latin America Anti-CD20 Monoclonal Antibodies Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Anti-CD20 Monoclonal Antibodies Sales by Country (2020-2031)
3.7.3 Latin America Anti-CD20 Monoclonal Antibodies Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Anti-CD20 Monoclonal Antibodies Market Facts & Figures by Country
3.8.1 Middle East and Africa Anti-CD20 Monoclonal Antibodies Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Anti-CD20 Monoclonal Antibodies Sales by Country (2020-2031)
3.8.3 Middle East and Africa Anti-CD20 Monoclonal Antibodies Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Anti-CD20 Monoclonal Antibodies Sales by Type (2020-2031)
4.1.1 Global Anti-CD20 Monoclonal Antibodies Sales by Type (2020-2025)
4.1.2 Global Anti-CD20 Monoclonal Antibodies Sales by Type (2026-2031)
4.1.3 Global Anti-CD20 Monoclonal Antibodies Sales Market Share by Type (2020-2031)
4.2 Global Anti-CD20 Monoclonal Antibodies Revenue by Type (2020-2031)
4.2.1 Global Anti-CD20 Monoclonal Antibodies Revenue by Type (2020-2025)
4.2.2 Global Anti-CD20 Monoclonal Antibodies Revenue by Type (2026-2031)
4.2.3 Global Anti-CD20 Monoclonal Antibodies Revenue Market Share by Type (2020-2031)
4.3 Global Anti-CD20 Monoclonal Antibodies Price by Type (2020-2031)
5 Segment by Application
5.1 Global Anti-CD20 Monoclonal Antibodies Sales by Application (2020-2031)
5.1.1 Global Anti-CD20 Monoclonal Antibodies Sales by Application (2020-2025)
5.1.2 Global Anti-CD20 Monoclonal Antibodies Sales by Application (2026-2031)
5.1.3 Global Anti-CD20 Monoclonal Antibodies Sales Market Share by Application (2020-2031)
5.2 Global Anti-CD20 Monoclonal Antibodies Revenue by Application (2020-2031)
5.2.1 Global Anti-CD20 Monoclonal Antibodies Revenue by Application (2020-2025)
5.2.2 Global Anti-CD20 Monoclonal Antibodies Revenue by Application (2026-2031)
5.2.3 Global Anti-CD20 Monoclonal Antibodies Revenue Market Share by Application (2020-2031)
5.3 Global Anti-CD20 Monoclonal Antibodies Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Genmab
6.1.1 Genmab Company Information
6.1.2 Genmab Description and Business Overview
6.1.3 Genmab Anti-CD20 Monoclonal Antibodies Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Genmab Anti-CD20 Monoclonal Antibodies Product Portfolio
6.1.5 Genmab Recent Developments/Updates
6.2 Amgen
6.2.1 Amgen Company Information
6.2.2 Amgen Description and Business Overview
6.2.3 Amgen Anti-CD20 Monoclonal Antibodies Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Amgen Anti-CD20 Monoclonal Antibodies Product Portfolio
6.2.5 Amgen Recent Developments/Updates
6.3 Celltrion
6.3.1 Celltrion Company Information
6.3.2 Celltrion Description and Business Overview
6.3.3 Celltrion Anti-CD20 Monoclonal Antibodies Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Celltrion Anti-CD20 Monoclonal Antibodies Product Portfolio
6.3.5 Celltrion Recent Developments/Updates
6.4 Roche
6.4.1 Roche Company Information
6.4.2 Roche Description and Business Overview
6.4.3 Roche Anti-CD20 Monoclonal Antibodies Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Roche Anti-CD20 Monoclonal Antibodies Product Portfolio
6.4.5 Roche Recent Developments/Updates
6.5 Novartis AG
6.5.1 Novartis AG Company Information
6.5.2 Novartis AG Description and Business Overview
6.5.3 Novartis AG Anti-CD20 Monoclonal Antibodies Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Novartis AG Anti-CD20 Monoclonal Antibodies Product Portfolio
6.5.5 Novartis AG Recent Developments/Updates
6.6 Pfizer
6.6.1 Pfizer Company Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Anti-CD20 Monoclonal Antibodies Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Pfizer Anti-CD20 Monoclonal Antibodies Product Portfolio
6.6.5 Pfizer Recent Developments/Updates
6.7 Biogen
6.7.1 Biogen Company Information
6.7.2 Biogen Description and Business Overview
6.7.3 Biogen Anti-CD20 Monoclonal Antibodies Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Biogen Anti-CD20 Monoclonal Antibodies Product Portfolio
6.7.5 Biogen Recent Developments/Updates
6.8 Genentech
6.8.1 Genentech Company Information
6.8.2 Genentech Description and Business Overview
6.8.3 Genentech Anti-CD20 Monoclonal Antibodies Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Genentech Anti-CD20 Monoclonal Antibodies Product Portfolio
6.8.5 Genentech Recent Developments/Updates
6.9 Immunomedics
6.9.1 Immunomedics Company Information
6.9.2 Immunomedics Description and Business Overview
6.9.3 Immunomedics Anti-CD20 Monoclonal Antibodies Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Immunomedics Anti-CD20 Monoclonal Antibodies Product Portfolio
6.9.5 Immunomedics Recent Developments/Updates
6.10 Spectrum Pharmaceuticals
6.10.1 Spectrum Pharmaceuticals Company Information
6.10.2 Spectrum Pharmaceuticals Description and Business Overview
6.10.3 Spectrum Pharmaceuticals Anti-CD20 Monoclonal Antibodies Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Spectrum Pharmaceuticals Anti-CD20 Monoclonal Antibodies Product Portfolio
6.10.5 Spectrum Pharmaceuticals Recent Developments/Updates
6.11 Bio-Rad Laboratories
6.11.1 Bio-Rad Laboratories Company Information
6.11.2 Bio-Rad Laboratories Description and Business Overview
6.11.3 Bio-Rad Laboratories Anti-CD20 Monoclonal Antibodies Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Bio-Rad Laboratories Anti-CD20 Monoclonal Antibodies Product Portfolio
6.11.5 Bio-Rad Laboratories Recent Developments/Updates
6.12 LFB Biotechnologie
6.12.1 LFB Biotechnologie Company Information
6.12.2 LFB Biotechnologie Description and Business Overview
6.12.3 LFB Biotechnologie Anti-CD20 Monoclonal Antibodies Sales, Revenue and Gross Margin (2020-2025)
6.12.4 LFB Biotechnologie Anti-CD20 Monoclonal Antibodies Product Portfolio
6.12.5 LFB Biotechnologie Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anti-CD20 Monoclonal Antibodies Industry Chain Analysis
7.2 Anti-CD20 Monoclonal Antibodies Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anti-CD20 Monoclonal Antibodies Production Mode & Process Analysis
7.4 Anti-CD20 Monoclonal Antibodies Sales and Marketing
7.4.1 Anti-CD20 Monoclonal Antibodies Sales Channels
7.4.2 Anti-CD20 Monoclonal Antibodies Distributors
7.5 Anti-CD20 Monoclonal Antibodies Customer Analysis
8 Anti-CD20 Monoclonal Antibodies Market Dynamics
8.1 Anti-CD20 Monoclonal Antibodies Industry Trends
8.2 Anti-CD20 Monoclonal Antibodies Market Drivers
8.3 Anti-CD20 Monoclonal Antibodies Market Challenges
8.4 Anti-CD20 Monoclonal Antibodies Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Genmab
Amgen Inc
Celltrion
Roche
Novartis
Pfizer Inc
Biogen
Genentech Inc
Immunomedics
Spectrum Pharmaceuticals
Bio Rad Laboratories
LFB Biotechnologie
List of Tables
 Table 1. Global Anti-CD20 Monoclonal Antibodies Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Anti-CD20 Monoclonal Antibodies Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Anti-CD20 Monoclonal Antibodies Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Anti-CD20 Monoclonal Antibodies Sales (KG) of Key Manufacturers (2020-2025)
 Table 5. Global Anti-CD20 Monoclonal Antibodies Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Anti-CD20 Monoclonal Antibodies Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Anti-CD20 Monoclonal Antibodies Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Anti-CD20 Monoclonal Antibodies Average Price (USD/KG) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Anti-CD20 Monoclonal Antibodies, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Anti-CD20 Monoclonal Antibodies, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Anti-CD20 Monoclonal Antibodies, Product Type & Application
 Table 12. Global Key Manufacturers of Anti-CD20 Monoclonal Antibodies, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Anti-CD20 Monoclonal Antibodies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-CD20 Monoclonal Antibodies as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Anti-CD20 Monoclonal Antibodies Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Anti-CD20 Monoclonal Antibodies Sales by Region (2020-2025) & (KG)
 Table 18. Global Anti-CD20 Monoclonal Antibodies Sales Market Share by Region (2020-2025)
 Table 19. Global Anti-CD20 Monoclonal Antibodies Sales by Region (2026-2031) & (KG)
 Table 20. Global Anti-CD20 Monoclonal Antibodies Sales Market Share by Region (2026-2031)
 Table 21. Global Anti-CD20 Monoclonal Antibodies Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Anti-CD20 Monoclonal Antibodies Revenue Market Share by Region (2020-2025)
 Table 23. Global Anti-CD20 Monoclonal Antibodies Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Anti-CD20 Monoclonal Antibodies Revenue Market Share by Region (2026-2031)
 Table 25. North America Anti-CD20 Monoclonal Antibodies Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Anti-CD20 Monoclonal Antibodies Sales by Country (2020-2025) & (KG)
 Table 27. North America Anti-CD20 Monoclonal Antibodies Sales by Country (2026-2031) & (KG)
 Table 28. North America Anti-CD20 Monoclonal Antibodies Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Anti-CD20 Monoclonal Antibodies Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Anti-CD20 Monoclonal Antibodies Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Anti-CD20 Monoclonal Antibodies Sales by Country (2020-2025) & (KG)
 Table 32. Europe Anti-CD20 Monoclonal Antibodies Sales by Country (2026-2031) & (KG)
 Table 33. Europe Anti-CD20 Monoclonal Antibodies Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Anti-CD20 Monoclonal Antibodies Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Anti-CD20 Monoclonal Antibodies Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Anti-CD20 Monoclonal Antibodies Sales by Region (2020-2025) & (KG)
 Table 37. Asia Pacific Anti-CD20 Monoclonal Antibodies Sales by Region (2026-2031) & (KG)
 Table 38. Asia Pacific Anti-CD20 Monoclonal Antibodies Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Anti-CD20 Monoclonal Antibodies Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Anti-CD20 Monoclonal Antibodies Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Anti-CD20 Monoclonal Antibodies Sales by Country (2020-2025) & (KG)
 Table 42. Latin America Anti-CD20 Monoclonal Antibodies Sales by Country (2026-2031) & (KG)
 Table 43. Latin America Anti-CD20 Monoclonal Antibodies Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Anti-CD20 Monoclonal Antibodies Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Anti-CD20 Monoclonal Antibodies Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Anti-CD20 Monoclonal Antibodies Sales by Country (2020-2025) & (KG)
 Table 47. Middle East and Africa Anti-CD20 Monoclonal Antibodies Sales by Country (2026-2031) & (KG)
 Table 48. Middle East and Africa Anti-CD20 Monoclonal Antibodies Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Anti-CD20 Monoclonal Antibodies Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Anti-CD20 Monoclonal Antibodies Sales (KG) by Type (2020-2025)
 Table 51. Global Anti-CD20 Monoclonal Antibodies Sales (KG) by Type (2026-2031)
 Table 52. Global Anti-CD20 Monoclonal Antibodies Sales Market Share by Type (2020-2025)
 Table 53. Global Anti-CD20 Monoclonal Antibodies Sales Market Share by Type (2026-2031)
 Table 54. Global Anti-CD20 Monoclonal Antibodies Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Anti-CD20 Monoclonal Antibodies Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Anti-CD20 Monoclonal Antibodies Revenue Market Share by Type (2020-2025)
 Table 57. Global Anti-CD20 Monoclonal Antibodies Revenue Market Share by Type (2026-2031)
 Table 58. Global Anti-CD20 Monoclonal Antibodies Price (USD/KG) by Type (2020-2025)
 Table 59. Global Anti-CD20 Monoclonal Antibodies Price (USD/KG) by Type (2026-2031)
 Table 60. Global Anti-CD20 Monoclonal Antibodies Sales (KG) by Application (2020-2025)
 Table 61. Global Anti-CD20 Monoclonal Antibodies Sales (KG) by Application (2026-2031)
 Table 62. Global Anti-CD20 Monoclonal Antibodies Sales Market Share by Application (2020-2025)
 Table 63. Global Anti-CD20 Monoclonal Antibodies Sales Market Share by Application (2026-2031)
 Table 64. Global Anti-CD20 Monoclonal Antibodies Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Anti-CD20 Monoclonal Antibodies Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Anti-CD20 Monoclonal Antibodies Revenue Market Share by Application (2020-2025)
 Table 67. Global Anti-CD20 Monoclonal Antibodies Revenue Market Share by Application (2026-2031)
 Table 68. Global Anti-CD20 Monoclonal Antibodies Price (USD/KG) by Application (2020-2025)
 Table 69. Global Anti-CD20 Monoclonal Antibodies Price (USD/KG) by Application (2026-2031)
 Table 70. Genmab Company Information
 Table 71. Genmab Description and Business Overview
 Table 72. Genmab Anti-CD20 Monoclonal Antibodies Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
 Table 73. Genmab Anti-CD20 Monoclonal Antibodies Product
 Table 74. Genmab Recent Developments/Updates
 Table 75. Amgen Company Information
 Table 76. Amgen Description and Business Overview
 Table 77. Amgen Anti-CD20 Monoclonal Antibodies Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
 Table 78. Amgen Anti-CD20 Monoclonal Antibodies Product
 Table 79. Amgen Recent Developments/Updates
 Table 80. Celltrion Company Information
 Table 81. Celltrion Description and Business Overview
 Table 82. Celltrion Anti-CD20 Monoclonal Antibodies Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
 Table 83. Celltrion Anti-CD20 Monoclonal Antibodies Product
 Table 84. Celltrion Recent Developments/Updates
 Table 85. Roche Company Information
 Table 86. Roche Description and Business Overview
 Table 87. Roche Anti-CD20 Monoclonal Antibodies Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
 Table 88. Roche Anti-CD20 Monoclonal Antibodies Product
 Table 89. Roche Recent Developments/Updates
 Table 90. Novartis AG Company Information
 Table 91. Novartis AG Description and Business Overview
 Table 92. Novartis AG Anti-CD20 Monoclonal Antibodies Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
 Table 93. Novartis AG Anti-CD20 Monoclonal Antibodies Product
 Table 94. Novartis AG Recent Developments/Updates
 Table 95. Pfizer Company Information
 Table 96. Pfizer Description and Business Overview
 Table 97. Pfizer Anti-CD20 Monoclonal Antibodies Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
 Table 98. Pfizer Anti-CD20 Monoclonal Antibodies Product
 Table 99. Pfizer Recent Developments/Updates
 Table 100. Biogen Company Information
 Table 101. Biogen Description and Business Overview
 Table 102. Biogen Anti-CD20 Monoclonal Antibodies Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
 Table 103. Biogen Anti-CD20 Monoclonal Antibodies Product
 Table 104. Biogen Recent Developments/Updates
 Table 105. Genentech Company Information
 Table 106. Genentech Description and Business Overview
 Table 107. Genentech Anti-CD20 Monoclonal Antibodies Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
 Table 108. Genentech Anti-CD20 Monoclonal Antibodies Product
 Table 109. Genentech Recent Developments/Updates
 Table 110. Immunomedics Company Information
 Table 111. Immunomedics Description and Business Overview
 Table 112. Immunomedics Anti-CD20 Monoclonal Antibodies Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
 Table 113. Immunomedics Anti-CD20 Monoclonal Antibodies Product
 Table 114. Immunomedics Recent Developments/Updates
 Table 115. Spectrum Pharmaceuticals Company Information
 Table 116. Spectrum Pharmaceuticals Description and Business Overview
 Table 117. Spectrum Pharmaceuticals Anti-CD20 Monoclonal Antibodies Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
 Table 118. Spectrum Pharmaceuticals Anti-CD20 Monoclonal Antibodies Product
 Table 119. Spectrum Pharmaceuticals Recent Developments/Updates
 Table 120. Bio-Rad Laboratories Company Information
 Table 121. Bio-Rad Laboratories Description and Business Overview
 Table 122. Bio-Rad Laboratories Anti-CD20 Monoclonal Antibodies Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
 Table 123. Bio-Rad Laboratories Anti-CD20 Monoclonal Antibodies Product
 Table 124. Bio-Rad Laboratories Recent Developments/Updates
 Table 125. LFB Biotechnologie Company Information
 Table 126. LFB Biotechnologie Description and Business Overview
 Table 127. LFB Biotechnologie Anti-CD20 Monoclonal Antibodies Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
 Table 128. LFB Biotechnologie Anti-CD20 Monoclonal Antibodies Product
 Table 129. LFB Biotechnologie Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Anti-CD20 Monoclonal Antibodies Distributors List
 Table 133. Anti-CD20 Monoclonal Antibodies Customers List
 Table 134. Anti-CD20 Monoclonal Antibodies Market Trends
 Table 135. Anti-CD20 Monoclonal Antibodies Market Drivers
 Table 136. Anti-CD20 Monoclonal Antibodies Market Challenges
 Table 137. Anti-CD20 Monoclonal Antibodies Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Anti-CD20 Monoclonal Antibodies
 Figure 2. Global Anti-CD20 Monoclonal Antibodies Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Anti-CD20 Monoclonal Antibodies Market Share by Type: 2024 & 2031
 Figure 4. First Generation Anti-CD20 Monoclonal Antibody Product Picture
 Figure 5. Second Generation Anti-CD20 Monoclonal Antibody Product Picture
 Figure 6. Third Generation Anti-CD20 Monoclonal Antibody Product Picture
 Figure 7. Global Anti-CD20 Monoclonal Antibodies Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Anti-CD20 Monoclonal Antibodies Market Share by Application: 2024 & 2031
 Figure 9. Oncology
 Figure 10. Neurology
 Figure 11. Immunology
 Figure 12. Global Anti-CD20 Monoclonal Antibodies Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Anti-CD20 Monoclonal Antibodies Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Anti-CD20 Monoclonal Antibodies Sales (2020-2031) & (KG)
 Figure 15. Global Anti-CD20 Monoclonal Antibodies Average Price (USD/KG) & (2020-2031)
 Figure 16. Anti-CD20 Monoclonal Antibodies Report Years Considered
 Figure 17. Anti-CD20 Monoclonal Antibodies Sales Share by Manufacturers in 2024
 Figure 18. Global Anti-CD20 Monoclonal Antibodies Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Anti-CD20 Monoclonal Antibodies Players: Market Share by Revenue in Anti-CD20 Monoclonal Antibodies in 2024
 Figure 20. Anti-CD20 Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Anti-CD20 Monoclonal Antibodies Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Anti-CD20 Monoclonal Antibodies Sales Market Share by Country (2020-2031)
 Figure 23. North America Anti-CD20 Monoclonal Antibodies Revenue Market Share by Country (2020-2031)
 Figure 24. U.S. Anti-CD20 Monoclonal Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Anti-CD20 Monoclonal Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Anti-CD20 Monoclonal Antibodies Sales Market Share by Country (2020-2031)
 Figure 27. Europe Anti-CD20 Monoclonal Antibodies Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Anti-CD20 Monoclonal Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Anti-CD20 Monoclonal Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Anti-CD20 Monoclonal Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Anti-CD20 Monoclonal Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Anti-CD20 Monoclonal Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Anti-CD20 Monoclonal Antibodies Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Anti-CD20 Monoclonal Antibodies Revenue Market Share by Region (2020-2031)
 Figure 35. China Anti-CD20 Monoclonal Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Anti-CD20 Monoclonal Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Anti-CD20 Monoclonal Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Anti-CD20 Monoclonal Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Anti-CD20 Monoclonal Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Taiwan Anti-CD20 Monoclonal Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Anti-CD20 Monoclonal Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Anti-CD20 Monoclonal Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Anti-CD20 Monoclonal Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Philippines Anti-CD20 Monoclonal Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Anti-CD20 Monoclonal Antibodies Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Anti-CD20 Monoclonal Antibodies Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Anti-CD20 Monoclonal Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Anti-CD20 Monoclonal Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Anti-CD20 Monoclonal Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Anti-CD20 Monoclonal Antibodies Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Anti-CD20 Monoclonal Antibodies Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Anti-CD20 Monoclonal Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Anti-CD20 Monoclonal Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. UAE Anti-CD20 Monoclonal Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Anti-CD20 Monoclonal Antibodies by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Anti-CD20 Monoclonal Antibodies by Type (2020-2031)
 Figure 57. Global Anti-CD20 Monoclonal Antibodies Price (USD/KG) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Anti-CD20 Monoclonal Antibodies by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Anti-CD20 Monoclonal Antibodies by Application (2020-2031)
 Figure 60. Global Anti-CD20 Monoclonal Antibodies Price (USD/KG) by Application (2020-2031)
 Figure 61. Anti-CD20 Monoclonal Antibodies Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global Anti CD25 Monoclonal Antibody Market Research Report 2024
Global Therapeutic Monoclonal Antibodies Market Research Report 2024
Global Monoclonal Antibody Drugs for Cancer Market Research Report 2024
Global Therapeutic Monoclonal Antibodies Drug Market Research Report 2024
Global CD20 Target Drug Market Research Report 2024
Global Cancer Monoclonal Antibody Partnering Terms and Agreements Market Insights Forecast to 2030
Global Arthritis Monoclonal Antibodies Market Research Report 2024
Global Monoclonal Antibodies for Non small Cell Lung Cancer Market Research Report 2025
Global Monoclonal Antibody for Gastric Cancer Market Research Report 2024
Global Conjugated Monoclonal Antibodies Market Research Report 2024
Global Hepatocellular Carcinoma Monoclonal Antibody Market Research Report 2025
Global CD25 IL2R alpha Antibody Market Research Report 2024
Biosimilars of Rituximab Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Fibronectin Monoclonal Antibody Market Research Report 2024
Global Anti TNF α Monoclonal Antibody Market Insights Forecast to 2030
Global Monoclonal Antibody VEGF Inhibitors Market Research Report 2024
Global Granulocytes Monoclonal Antibody Market Research Report 2024
Global Monoclonal Antibodies Product Market Research Report 2024
Global CD38 Monoclonal Antibodies Market Research Report 2024
Global Erythrocytes Monoclonal Antibody Market Research Report 2024

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5L19798
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28I6901
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22R9736
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29A2598
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions